Yamamoto Hiroshi, Kishi Toshiro, Lee Charlotte E, Choi Brian J, Fang Hui, Hollenberg Anthony N, Drucker Daniel J, Elmquist Joel K
Department of Medicine and Division of Endocrinology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
J Neurosci. 2003 Apr 1;23(7):2939-46. doi: 10.1523/JNEUROSCI.23-07-02939.2003.
Glucagon-like peptide-1 (GLP-1) released from the gut is an incretin that stimulates insulin secretion. GLP-1 is also a brain neuropeptide that has diverse central actions, including inhibition of food and water intake, gastric emptying, and stimulation of neuroendocrine responses characteristic of visceral illness. Both intravenous and intracerebroventricular administration of GLP-1 receptor (GLP-1R) agonists increase blood pressure and heart rate and induce Fos-like immunoreactivity (Fos-IR) in autonomic regulatory sites in the rat brain. The area postrema (AP) is a circumventricular organ and has been implicated in processing visceral sensory information. GLP-1Rs are densely expressed in the AP, and peripheral GLP-1R agonists induce Fos-IR in AP neurons to a greater degree than intracerebroventricular administration. Because the AP lacks a blood-brain barrier, we hypothesized that the AP is a key site for peripheral GLP-1 to activate central autonomic regulatory sites. In this study, we found that many tyrosine hydroxylase (TH)-containing neurons in the AP expressed GLP-1Rs and Fos-IR after intravenous GLP-1R agonists. Furthermore, intravenous but not intracerebroventricular GLP-1R agonists induced TH transcription in the AP in vivo. In addition, GLP-1R agonists directly activated TH transcription in an in vitro cell system. Finally, we found that GLP-1-responsive TH neurons in the AP innervate autonomic control sites, including the parabrachial nucleus, nucleus of solitary tract, and ventrolateral medulla. These findings suggest that catecholamine neurons in the AP link peripheral GLP-1 and central autonomic control sites that mediate the diverse neuroendocrine and autonomic actions of peripheral GLP-1.
从肠道释放的胰高血糖素样肽-1(GLP-1)是一种肠促胰岛素,可刺激胰岛素分泌。GLP-1也是一种脑内神经肽,具有多种中枢作用,包括抑制食物和水的摄入、胃排空,以及刺激内脏疾病特有的神经内分泌反应。静脉注射和脑室内注射GLP-1受体(GLP-1R)激动剂均可增加大鼠血压和心率,并在大鼠脑内自主神经调节位点诱导Fos样免疫反应性(Fos-IR)。最后区(AP)是一个室周器官,与内脏感觉信息处理有关。GLP-1R在AP中密集表达,外周GLP-1R激动剂比脑室内注射更能诱导AP神经元中的Fos-IR。由于AP缺乏血脑屏障,我们推测AP是外周GLP-1激活中枢自主神经调节位点的关键部位。在本研究中,我们发现静脉注射GLP-1R激动剂后,AP中许多含酪氨酸羟化酶(TH)的神经元表达GLP-1R和Fos-IR。此外,静脉注射而非脑室内注射GLP-1R激动剂可在体内诱导AP中的TH转录。此外,GLP-1R激动剂在体外细胞系统中直接激活TH转录。最后,我们发现AP中对GLP-1有反应的TH神经元支配自主神经控制位点,包括臂旁核、孤束核和延髓腹外侧。这些发现表明,AP中的儿茶酚胺能神经元连接外周GLP-1和中枢自主神经控制位点,介导外周GLP-1的多种神经内分泌和自主神经作用。